Non-invasive evaluation of hepatic manifestation in Wilson disease with transient elastography, ARFI, and different fibrosis scores

Scandinavian Journal of Gastroenterology

Volumn 47, Issue 11, 2012, Pages 1353-1361

  Karlas, Thomas ^a   Hempel, Maria ^a   Tröltzsch, Michael ^a   Huster, Dominik ^b   Günther, Peter ^a   Tenckhoff, Hannelore ^a   Mössner, Joachim ^a   Berg, Thomas ^a   Keim, Volker ^a   Wiegand, Johannes ^a  

^a UNIVERSITY HOSPITAL LEIPZIG   (Germany)

^b Deaconess Hospital Leipzig   (Germany)

Author keywords

APRI; ARFI; FIB 4; Forns score; Liver fibrosis; Transient elastography; Wilson's disease

Indexed keywords

ACOUSTIC RADIATION FORCE IMPULSE IMAGING; ADULT; ARTICLE; AST PLATELET RATIO INDEX; CONTROLLED STUDY; CORRELATION ANALYSIS; CORRELATION COEFFICIENT; ELASTOGRAPHY; FEASIBILITY STUDY; FEMALE; FIB 4 SCORE; FORNS SCORE; HUMAN; LIVER CIRRHOSIS; LIVER FIBROSIS; MALE; NON INVASIVE PROCEDURE; PRIORITY JOURNAL; SCORING SYSTEM; ULTRASOUND BASED TRANSIENT ELASTOGRAPHY; WILSON DISEASE;

ADULT; AREA UNDER CURVE; ASPARTATE AMINOTRANSFERASES; ELASTICITY IMAGING TECHNIQUES; FEMALE; HEPATOLENTICULAR DEGENERATION; HUMANS; LIVER CIRRHOSIS; MALE; MIDDLE AGED; PLATELET COUNT; ROC CURVE; SEVERITY OF ILLNESS INDEX; STATISTICS, NONPARAMETRIC;

EID: 84867493797     PISSN: 00365521     EISSN: 15027708     Source Type: Journal    
DOI: 10.3109/00365521.2012.719924     Document Type: Article

References (29)

1. Huster D. Wilson disease. Best Pract Res Clin Gastroenterol 2010;24:531-9.
2. Merle U, Schaefer M, Ferenci P, Stremmel W. Clinical presentation, diagnosis and long-term outcome of Wilson's disease: a cohort study. Gut 2007;56:115-20. (Pubitemid 46044897)
3. Bruha R, Marecek Z, Pospisilova L, Nevsimalova S, Vitek L, Martasek P, et al. Long-term follow-up of Wilson disease: natural history, treatment, mutations analysis and phenotypic correlation. Liver Int 2011;31:83-91.
4. Ferenci P, Caca K, Loudianos G, Mieli-Vergani G, Tanner S, Sternlieb I, et al. Diagnosis and phenotypic classification of Wilson disease. Liver Int 2003;23:139-42. (Pubitemid 37265785)
5. Weiss KH, Stremmel W. Evolving perspectives in Wilson disease: diagnosis, treatment and monitoring. Curr Gastroenterol Rep 2012;14:1-7.
6. Friedrich-Rust M, Nierhoff J, Lupsor M, Sporea I, Fierbinteanu- Braticevici C, Strobel D, et al. Performance of Acoustic Radiation Force Impulse imaging for the staging of liver fibrosis: a pooled meta-analysis. J Viral Hepat 2012; 19:e212-19.
7. Colombo S, Buonocore M, Del Poggio A, Jamoletti C, Elia S, Mattiello M, et al. Head-to-head comparison of transient elastography (TE), real-time tissue elastography (RTE), and acoustic radiation force impulse (ARFI) imaging in the diagnosis of liver fibrosis. J Gastroenterol 2012;47: 461-9.
8. Gaia S, Carenzi S, Barilli AL, Bugianesi E, Smedile A, Brunello F, et al. Reliability of transient elastography for the detection of fibrosis in non-alcoholic fatty liver disease and chronic viral hepatitis. J Hepatol 2011;54:64-71.
9. Friedrich-Rust M, Romen D, Vermehren J, Kriener S, Sadet D, Herrmann E, et al. Acoustic radiation force impulse-imaging and transient elastography for non-invasive assessment of liver fibrosis and steatosis in NAFLD. Eur J Radiol 2012;81:e325-31.
10. Nahon P, Kettaneh A, Tengher-Barna I, Ziol M, de Lédinghen V, Douvin C, et al. Assessment of liver fibrosis using transient elastography in patients with alcoholic liver disease. J Hepatol 2008;49:1062-8.
11. Zarski J, Sturm N, Guechot J, Paris A, Zafrani ES, Asselah T, et al. Comparison of nine blood tests and transient elastography for liver fibrosis in chronic hepatitis C: The ANRS HCEP-23 study. J Hepatol 2012;56:55-62.
12. de Lédinghen V, Vergniol J. Transient elastography for the diagnosis of liver fibrosis. Expert Rev Med Devices 2010;7: 811-23.
13. Sebastiani G, Castera L, Halfon P, Pol S, Mangia A, Di Marco V, et al. The impact of liver disease aetiology and the stages of hepatic fibrosis on the performance of non-invasive fibrosis biomarkers: an international study of 2411 cases. Aliment Pharmacol Ther 2011;34:1202-16.
14. European Association For The Study Of The Liver. EASL Clinical practice guidelines: Wilson's disease. J Hepatol 2012;56:671-85.
15. Castéra L, Foucher J, Bernard PH, Carvalho F, Allaix D, Merrouche W, et al. Pitfalls of liver stiffness measurement: a 5-year prospective study of 13.369 examinations. Hepatology 2010;51:828-35.
16. Zhai L, Palmeri ML, Bouchard RR, Nightingale RW, Nightingale KR. An integrated indenter-ARFI imaging system for tissue stiffness quantification. Ultrason Imaging 2008;30:95-111.
17. Karlas T, Pfrepper C, Wiegand J, Wittekind C, Neuschulz M, Mössner J, et al. Acoustic radiation force impulse imaging (ARFI) for non-invasive detection of liver fibrosis: examination standards and evaluation of interlobe differences in healthy subjects and chronic liver disease. Scand J Gastroenterol 2011;46:1458-67.
18. Bota S, Sporea I, Sirli R, Popescu A, Danial M, Sendroiu M. Factors that influence the correlation of acoustic radiation force impulse (ARFI) elastography with liver fibrosis. Med Ultrason 2011;13:135-40.
19. Lin ZH, Xin YN, Dong QJ, Wang Q, Jiang XJ, Zhan SH, et al. Performance of the aspartate aminotransferase-to-platelet ratio index for the staging of hepatitis C-related fibrosis: an updated meta-analysis. Hepatology 2011;53: 726-36.
20. Vallet-Pichard A, Mallet V, Nalpas B, Verkarre V, Nalpas A, Dhalluin-Venier V, et al. FIB-4: an inexpensive and accurate marker of fibrosis in HCV infection. Comparison with liver biopsy and fibrotest. Hepatology 2007;46:32-6. (Pubitemid 47171918)
21. Forns X, Ampurdanès S, Llovet JM, Aponte J, Quintó L, Martínez-Bauer E, et al. Identification of chronic hepatitis C patients without hepatic fibrosis by a simple predictive model. Hepatology 2002;36:986-92.
22. DeLong ER, DeLong DM, Clarke-Pearson DL. Comparing the areas under two or more correlated receiver operating characteristic curves: a nonparametric approach. Biometrics 1988;44:837-45.
23. Delacour H, Servonnet A, Perrot A, Vigezzi JF, Ramirez JM. La courbe ROC (receiver operating characteristic): principes et principales applications en biologie clinique. Ann Biol Clin 2005;63:145-54. (Pubitemid 40428453)
24. Stebbing J, Farouk L, Panos G, Anderson M, Jiao LR, Mandalia S, et al. A meta-analysis of transient elastography for the detection of hepatic fibrosis. J Clin Gastroenterol 2010;44:214-19.
25. Bedossa P, Carrat F. Liver biopsy: the best, not the gold standard. J Hepatol 2009;50:1-3.
26. Sini M, Sorbello O, Civolani A, Liggi M, Demelia L. Non-invasive assessment of hepatic fibrosis in a series of patients with Wilson's Disease. Dig Liver Dis 2012;44: 487-91.
27. Stromeyer FW, Ishak KG. Histology of the liver in Wilson's disease: a study of 34 cases. Am J Clin Pathol 1980;73:12-24. (Pubitemid 10180389)
28. Kazemi K, Geramizadeh B, Nikeghbalian S, Salahi H, Bahador A, Reza Nejatollahi SM, et al. Effect of D-penicillamine on liver fibrosis and inflammation in Wilson disease. Exp Clin Transplant 2008;6:261-3.
29. Castera L, Pinzani M. Biopsy and non-invasive methods for the diagnosis of liver fibrosis: does it take two to tango? Gut 2010;59:861-6.